CEACAM5 and neoplasm: One of the recommended approaches is the combination of CA 19-9 with other commonly used tumor markers, including CEA, CA 125, and CA 242, as well as novel markers such as macrophage inhibitory cytokine-1, mucin 5AC (MUC5AC) [86,87].